26783546|t|Cerebrospinal fluid neurogranin and YKL-40 as biomarkers of Alzheimer's disease.
26783546|a|OBJECTIVE: Widespread implementation of cerebrospinal fluid (CSF) biomarkers of Alzheimer's disease (AD) in clinical settings requires improved accuracy for diagnosis of prodromal disease and for distinguishing AD from non-AD dementias. Novel and promising CSF biomarkers include neurogranin, a marker of synaptic degeneration, and YKL-40, a marker of neuroinflammation. METHODS: CSF neurogranin and YKL-40 were measured in a cohort of 338 individuals including cognitively healthy controls and patients with stable mild cognitive impairment (sMCI), MCI who later developed AD (MCI-AD), AD dementia, Parkinson's disease dementia (PDD), dementia with Lewy bodies (DLB), vascular dementia (VaD), and frontotemporal dementia (FTD). The diagnostic accuracy of neurogranin and YKL-40 were compared with the core AD biomarkers, beta-amyloid (Abeta42 and Abeta40) and tau. RESULTS: Neurogranin levels were increased in AD and decreased in non-AD dementia compared with healthy controls. As a result, AD patients showed considerably higher CSF levels of neurogranin than DLB/PDD, VaD and FTD patients. CSF YKL-40 levels were increased in AD compared with DLB/PDD but not with VaD or FTD. Neither CSF neurogranin nor YKL-40 levels differed significantly between sMCI patients and MCI-AD patients. Both biomarkers correlated positively with CSF Abeta40 and tau. CSF neurogranin and YKL-40 could separate AD dementia from non-AD dementias (neurogranin, area under the curve [AUC] = 0.761; YKL-40, AUC = 0.604; Abeta42/neurogranin, AUC = 0.849; Abeta42/YKL-40, AUC = 0.785), but the diagnostic accuracy was not better compared to CSF Abeta and tau (Abeta42, AUC = 0.755; tau AUC = 0.858; Abeta42/tau, AUC = 0.895; Abeta42/Abeta40, AUC = 0.881). Similar results were obtained when separating sMCI from MCI-AD cases. INTERPRETATION: CSF neurogranin and YKL-40 do not improve the diagnostic accuracy of either prodromal AD or AD dementia when compared to the core CSF AD biomarkers. Nevertheless, the CSF level of neurogranin is selectively increased in AD dementia, whereas YKL-40 is increased in both AD and FTD suggesting that synaptic degeneration and glial activation may be important in these neurodegenerative conditions.
26783546	20	31	neurogranin	Gene	4900
26783546	36	42	YKL-40	Gene	1116
26783546	60	79	Alzheimer's disease	Disease	MESH:D000544
26783546	161	180	Alzheimer's disease	Disease	MESH:D000544
26783546	182	184	AD	Disease	MESH:D000544
26783546	292	294	AD	Disease	MESH:D000544
26783546	304	316	AD dementias	Disease	MESH:D000544
26783546	361	372	neurogranin	Gene	4900
26783546	386	407	synaptic degeneration	Disease	MESH:D012183
26783546	413	419	YKL-40	Gene	1116
26783546	433	450	neuroinflammation	Disease	MESH:D000090862
26783546	465	476	neurogranin	Gene	4900
26783546	481	487	YKL-40	Gene	1116
26783546	576	584	patients	Species	9606
26783546	602	622	cognitive impairment	Disease	MESH:D003072
26783546	624	628	sMCI	Disease	MESH:D060825
26783546	631	634	MCI	Disease	
26783546	655	657	AD	Disease	MESH:D000544
26783546	659	662	MCI	Disease	
26783546	663	665	AD	Disease	MESH:D000544
26783546	668	679	AD dementia	Disease	MESH:D000544
26783546	681	709	Parkinson's disease dementia	Disease	MESH:D010300
26783546	711	714	PDD	Disease	MESH:D010300
26783546	717	742	dementia with Lewy bodies	Disease	MESH:D020961
26783546	744	747	DLB	Disease	MESH:D020961
26783546	750	767	vascular dementia	Disease	MESH:D015140
26783546	769	772	VaD	Disease	MESH:D015140
26783546	779	802	frontotemporal dementia	Disease	MESH:D057180
26783546	804	807	FTD	Disease	MESH:D057180
26783546	837	848	neurogranin	Gene	4900
26783546	853	859	YKL-40	Gene	1116
26783546	888	890	AD	Disease	MESH:D000544
26783546	917	924	Abeta42	Gene	351
26783546	942	945	tau	Gene	4137
26783546	956	967	Neurogranin	Gene	4900
26783546	993	995	AD	Disease	MESH:D000544
26783546	1017	1028	AD dementia	Disease	MESH:D000544
26783546	1074	1076	AD	Disease	MESH:D000544
26783546	1077	1085	patients	Species	9606
26783546	1127	1138	neurogranin	Gene	4900
26783546	1144	1147	DLB	Disease	MESH:D020961
26783546	1148	1151	PDD	Disease	MESH:D010300
26783546	1153	1156	VaD	Disease	MESH:D015140
26783546	1161	1164	FTD	Disease	MESH:D057180
26783546	1165	1173	patients	Species	9606
26783546	1179	1185	YKL-40	Gene	1116
26783546	1211	1213	AD	Disease	MESH:D000544
26783546	1228	1231	DLB	Disease	MESH:D020961
26783546	1232	1235	PDD	Disease	MESH:D010300
26783546	1249	1252	VaD	Disease	MESH:D015140
26783546	1256	1259	FTD	Disease	MESH:D057180
26783546	1273	1284	neurogranin	Gene	4900
26783546	1289	1295	YKL-40	Gene	1116
26783546	1334	1338	sMCI	Disease	MESH:D060825
26783546	1339	1347	patients	Species	9606
26783546	1352	1355	MCI	Disease	
26783546	1356	1358	AD	Disease	MESH:D000544
26783546	1359	1367	patients	Species	9606
26783546	1428	1431	tau	Gene	4137
26783546	1437	1448	neurogranin	Gene	4900
26783546	1453	1459	YKL-40	Gene	1116
26783546	1475	1486	AD dementia	Disease	MESH:D000544
26783546	1496	1508	AD dementias	Disease	MESH:D000544
26783546	1510	1521	neurogranin	Gene	4900
26783546	1559	1565	YKL-40	Gene	1116
26783546	1580	1587	Abeta42	Gene	351
26783546	1588	1599	neurogranin	Gene	4900
26783546	1614	1621	Abeta42	Gene	351
26783546	1622	1628	YKL-40	Gene	1116
26783546	1703	1708	Abeta	Gene	351
26783546	1713	1716	tau	Gene	4137
26783546	1718	1725	Abeta42	Gene	351
26783546	1740	1743	tau	Gene	4137
26783546	1757	1764	Abeta42	Gene	351
26783546	1765	1768	tau	Gene	4137
26783546	1783	1790	Abeta42	Gene	351
26783546	1860	1864	sMCI	Disease	MESH:D060825
26783546	1870	1873	MCI	Disease	
26783546	1874	1876	AD	Disease	MESH:D000544
26783546	1904	1915	neurogranin	Gene	4900
26783546	1920	1926	YKL-40	Gene	1116
26783546	1986	1988	AD	Disease	MESH:D000544
26783546	1992	2003	AD dementia	Disease	MESH:D000544
26783546	2034	2036	AD	Disease	MESH:D000544
26783546	2080	2091	neurogranin	Gene	4900
26783546	2120	2131	AD dementia	Disease	MESH:D000544
26783546	2141	2147	YKL-40	Gene	1116
26783546	2169	2171	AD	Disease	MESH:D000544
26783546	2176	2179	FTD	Disease	MESH:D057180
26783546	2196	2217	synaptic degeneration	Disease	MESH:D012183
26783546	2265	2293	neurodegenerative conditions	Disease	MESH:D019636
26783546	Association	MESH:D000090862	1116
26783546	Association	1116	351
26783546	Positive_Correlation	MESH:D000544	4900
26783546	Association	MESH:D012183	4900
26783546	Association	MESH:D000544	1116

